Skip to content

Prospective multicenter study on innovative vascular reconciliation technology in acute ischemic stroke

Prospective multicenter study on innovative vascular reconciliation technology in acute ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105102
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

Observation group:None

Sponsors

Changzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1:   Age >= 18 years old 2:   mRS score <= 2 points (before onset of the disease) 3:   Within 24 hours of onset (time from the onset to the completion of femoral artery puncture) 4:   Patients with CTA, MRA or contrast DSA diagnosed with acute ischemic stroke 5:   Patients are willing to follow-up evaluation according to the requirements of the clinical research plan 6:  Patients who can understand the purpose of the study, volunteer to participate, and sign informed consent forms

Exclusion criteria

Exclusion criteria: 1:   Life expectancy 3.0 or platelet count 22.2 mmol/L 12:   Uncontrolled hypertension (systolic BP >185mmHg or diastolic BP >110mmHg) 13:   Stroke onset with epilepsy 14:   Tortuous vascular access making retrieval devices difficult to reach/travel 15:   Intracranial hemorrhage (except microbleeds, decision based on location/quantity) 16:   Space-occupying intracranial lesions (except meningiomas) 17:   Acute occlusions in different vascular territories (e.g., bilateral anterior or combined anterior-posterior) 18:   Proximal target vessel chronic occlusion requiring treatment 19:   Common carotid/vertebral artery occlusions with known/suspected chronic target vessel occlusion 20:   Other conditions deemed unsuitable by investigators

Design outcomes

Primary

MeasureTime frame
Good prognosis at 90 days after surgery;

Secondary

MeasureTime frame
Successful vascular recanalization rate after first aspiration or thrombectomy;Incidence of asymptomatic intracranial hemorrhage (aICH);Incidence of symptomatic intracranial hemorrhage (sICH);Successful vascular recanalization time;Good rate of postoperative NIHSS score;

Countries

China

Contacts

Public ContactYa Peng

Changzhou First People's Hospital

neuropengya@sina.com+86 130 9317 8444

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026